Critical Advances in the Evolving Science and Medicine of STEMI Management and High-Risk ACS

WebCAST CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Release Date:

May 10, 2009

Expiration Date:

May 10, 2011

Intended Audience:

Cardiologists, interventional cardiologists, emergency medicine specialists, prehospital care providers, critical care physicians and intensivists, hospitalists and hospital pharmacists

Registration:

Enrollment for this WebCAST is complimentary, and clinicians are invited to participate in this CME-certified WebCAST and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an independent
educational grant from
The Medicines Company.

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School, Office of CME and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Program Faculty and Disclosures:

Sunil V. Rao, MD, FACC – Program Moderator
Assistant Professor of Medicine
Duke University Medical Center
Director, Cardiac Catheterization Laboratories
Durham VA Medical Center
Durham, NC

Grant Funding: Cordis Corporation, Momenta Pharmaceuticals, Portola Pharmaceuticals
Consultant: The Medicines Company, Bristol-Myers Squibb, sanofi-aventis
Speakers’ Bureau: The Medicines Company, Bristol-Myers Squibb, sanofi-aventis


Gregg W. Stone, MD, FACC
Professor of Medicine
Columbia University Medical Center
Chairman
The Cardiovascular Research Foundation
New York, NY

Research Support: The Medicines Company
Honoraria: Eli Lilly

Prof. Dr. Christian Hamm, MD
Professor and Director
Department of Cardiology
Kerckhoff-Klinik Center
Bad Nauheim, Germany

Consulting Fees/Honoraria: GlaxoSmithKline, Medtronic, CV Therapeutics, The Medicines Company, sanofi-aventis, Abbott, Boehringer Ingelheim, Pfizer and Eli Lilly and Company
Clinical research support: Merck, Siemens, and Boston Scientific

Prof. Philippe Gabriel Steg, MD
Professor of Cardiology
Universite Paris 7 Denis Diderot
Director, CCU
Centre Hospitalier Bichat Claude Bernard
Paris, France

Research Grant: sanofi-aventis Speakers Bureau: Boehringer-Ingelheim, BMS, GSK,
Medtronic, Nycomed, sanofi-aventis, Servier, The Medicines Company
Consulting/Advisory Board: Astellas, AstraZeneca, Bayer, Boehringer-Ingelheim, BMS, Endotis,
GSK, Medtronic, MSD, Nycomed, sanofi-aventis, Servier, The Medicines Company

Educational Objectives:

Participants in this CME-certified WebCAST will:

• Learn how recently issued Year 2008 ESC and AHA/ACC focused guidelines for STEMI and high-risk ACS are best implemented in the setting of PPCI
• Learn to understand the implications of recent clinical data, landmark trials, new stent technologies, and consensus recom mendations for catheterization lab-based management of STEMI and high-risk ACS
• Learn how interventional cardiologists can best address the triple threats of thrombosis, mortality, and bleeding when managing STEMI and high-risk ACS patients in the catheterization laboratory
• Learn how recent advances and trials focused on DES, thrombus aspiration, site access, and other technological advances can optimize outcomes in patients with STEMI and high-risk ACS
  
  

Disclaimer:

Copyright © 2009 by Pharmatecture, LLC and CMEducation Resources, LLC All rights reserved.

Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2009 All rights reserved